Safety of Cemiplimab in Kidney Transplant Recipients with Cutaneous Squamous Cell Carcinoma maintained on the CONTRAC regimen: A Retrospective Cohort Study of Ten Patients, Supplemental Materials

Published: 26 May 2026| Version 2 | DOI: 10.17632/dfxngndv6f.2
Contributor:
Nina Ran

Description

Supplemental Figures for the Manuscript: Safety of Cemiplimab in Kidney Transplant Recipients with Cutaneous Squamous Cell Carcinoma maintained on the CONTRAC regimen: A Retrospective Cohort Study of Ten Patients

Files

Categories

Skin Cancer

Licence